Holders — by stockHoldings — by fund
DIADEMA PARTNERS LP
Everything this manager disclosed owning in US-listed stocks — its complete Form 13F portfolio · as of 2026-06-30 · filed with the SEC up to 45 days after quarter end · CIK 2026172
$791.3M
disclosed book value
116
positions
6%
largest position share
Positions, as of 2026-06-30
top 100 of 116 · 13F covers long US-listed positions only — cash, bonds, private and foreign stakes are not disclosed · PUT/CALL tags = options positions (share-equivalents), not shares held
| # | Issuer | Shares | Value | % of book |
|---|---|---|---|---|
| 1 | VKTXVIKING THERAPEUTICS INCCALL | 1.2M | $47.6M | 6% |
| 2 | ABVXABIVAX SACALL | 349,200 | $46.5M | 5.9% |
| 3 | BMYBRISTOL-MYERS SQUIBB COCALL | 600,000 | $34.6M | 4.4% |
| 4 | ABVXABIVAX SAPUT | 252,400 | $33.6M | 4.3% |
| 5 | UTHRUNITED THERAPEUTICS CORP DEL | 52,989 | $28.7M | 3.6% |
| 6 | RVMDREVOLUTION MEDICINES INC | 139,218 | $26.1M | 3.3% |
| 7 | ABVXABIVAX SA | 163,644 | $21.6M | 2.7% |
| 8 | COGTCOGENT BIOSCIENCES INC | 493,664 | $19.1M | 2.4% |
| 9 | BMYBRISTOL-MYERS SQUIBB COPUT | 330,600 | $19.0M | 2.4% |
| 10 | BBIO 1.75 03/01/31BRIDGEBIO PHARMA INC | 250,000 | $18.6M | 2.4% |
| 11 | CORTCORCEPT THERAPEUTICS INCCALL | 206,300 | $17.9M | 2.3% |
| 12 | BMRNBIOMARIN PHARMACEUTICAL INC | 312,846 | $17.9M | 2.3% |
| 13 | VKTXVIKING THERAPEUTICS INC | 441,808 | $17.2M | 2.2% |
| 14 | KYMRKYMERA THERAPEUTICS INCCALL | 149,700 | $17.2M | 2.2% |
| 15 | NVSNOVARTIS AGPUT | 100,000 | $15.7M | 2% |
| 16 | UNIQURE NVPUT | 299,000 | $13.8M | 1.7% |
| 17 | VKTXVIKING THERAPEUTICS INCPUT | 350,500 | $13.7M | 1.7% |
| 18 | BIIBBIOGEN INCCALL | 60,000 | $13.0M | 1.6% |
| 19 | CAPRCAPRICOR THERAPEUTICS INCPUT | 534,400 | $12.9M | 1.6% |
| 20 | SMMTSUMMIT THERAPEUTICS INCCALL | 860,200 | $12.5M | 1.6% |
| 21 | LLYELI LILLY & COPUT | 10,000 | $12.0M | 1.5% |
| 22 | INCYINCYTE CORPPUT | 105,400 | $11.9M | 1.5% |
| 23 | EWTXEDGEWISE THERAPEUTICS INC | 272,214 | $11.1M | 1.4% |
| 24 | UNIQURE NVCALL | 235,400 | $10.8M | 1.4% |
| 25 | BNTXBIONTECH SECALL | 100,000 | $9.3M | 1.2% |
| 26 | KODKODIAK SCIENCES INC | 218,117 | $8.5M | 1.1% |
| 27 | IMCRIMMUNOCORE HLDGS PLC | 254,863 | $8.1M | 1% |
| 28 | CAPRCAPRICOR THERAPEUTICS INCCALL | 329,300 | $7.9M | 1% |
| 29 | NVSNOVARTIS AGCALL | 50,000 | $7.8M | 1% |
| 30 | REPLREPLIMUNE GROUP INCCALL | 696,300 | $7.7M | 1% |
| 31 | KODKODIAK SCIENCES INCCALL | 196,700 | $7.7M | 1% |
| 32 | FDMT4D MOLECULAR THERAPEUTICS IN | 571,107 | $7.6M | 1% |
| 33 | MRNAMODERNA INCPUT | 100,000 | $7.0M | 0.9% |
| 34 | HIMSHIMS & HERS HEALTH INCCALL | 200,000 | $6.9M | 0.9% |
| 35 | RCUSARCUS BIOSCIENCES INC | 223,810 | $6.9M | 0.9% |
| 36 | HIMSHIMS & HERS HEALTH INCPUT | 193,700 | $6.7M | 0.8% |
| 37 | CRBPCORBUS PHARMACEUTICALS HLDGSCALL | 633,800 | $5.9M | 0.8% |
| 38 | SLSSELLAS LIFE SCIENCES GROUP ICALL | 400,000 | $5.9M | 0.7% |
| 39 | KODKODIAK SCIENCES INCPUT | 146,900 | $5.7M | 0.7% |
| 40 | ALMSALUMIS INCCALL | 200,000 | $5.6M | 0.7% |
| 41 | ROYALTY PHARMA PLCCALL | 100,000 | $5.6M | 0.7% |
| 42 | JNJJOHNSON & JOHNSON | 22,000 | $5.6M | 0.7% |
| 43 | REPLREPLIMUNE GROUP INCPUT | 502,500 | $5.6M | 0.7% |
| 44 | BIOABIOAGE LABS INCCALL | 200,100 | $4.9M | 0.6% |
| 45 | NVONOVO-NORDISK A S | 100,000 | $4.8M | 0.6% |
| 46 | BIOHAVEN LTDCALL | 317,000 | $4.7M | 0.6% |
| 47 | TENXTENAX THERAPEUTICS INCCALL | 307,000 | $4.5M | 0.6% |
| 48 | CRVSCORVUS PHARMACEUTICALS INC | 294,811 | $4.4M | 0.6% |
| 49 | RLAYRELAY THERAPEUTICS INC | 230,677 | $4.3M | 0.5% |
| 50 | TGTXTG THERAPEUTICS INCCALL | 75,700 | $4.2M | 0.5% |
| 51 | GLUEMONTE ROSA THERAPEUTICS INCCALL | 170,100 | $4.1M | 0.5% |
| 52 | RCUSARCUS BIOSCIENCES INCCALL | 124,000 | $3.8M | 0.5% |
| 53 | UNCYUNICYCIVE THERAPEUTICS INCCALL | 792,600 | $3.7M | 0.5% |
| 54 | ZYMEZYMEWORKS INC | 142,132 | $3.7M | 0.5% |
| 55 | AMGNAMGEN INCCALL | 10,000 | $3.6M | 0.5% |
| 56 | BIOABIOAGE LABS INC | 146,334 | $3.6M | 0.5% |
| 57 | TSHATAYSHA GENE THERAPIES INC | 522,619 | $3.6M | 0.4% |
| 58 | NTLAINTELLIA THERAPEUTICS INCCALL | 200,000 | $3.4M | 0.4% |
| 59 | CLDXCELLDEX THERAPEUTICS INC NEWPUT | 86,000 | $3.2M | 0.4% |
| 60 | PCVXVAXCYTE INCCALL | 53,100 | $3.1M | 0.4% |
| 61 | NRIXNURIX THERAPEUTICS INC | 121,539 | $2.9M | 0.4% |
| 62 | SMMTSUMMIT THERAPEUTICS INCPUT | 200,000 | $2.9M | 0.4% |
| 63 | PCVXVAXCYTE INCPUT | 48,900 | $2.8M | 0.4% |
| 64 | CRBPCORBUS PHARMACEUTICALS HLDGS | 301,264 | $2.8M | 0.4% |
| 65 | INDVINDIVIOR PHARMACEUTICALS INC | 67,512 | $2.8M | 0.4% |
| 66 | IVAINVENTIVA SA | 740,786 | $2.7M | 0.3% |
| 67 | NVONOVO-NORDISK A SPUT | 55,900 | $2.7M | 0.3% |
| 68 | ORKAORUKA THERAPEUTICS INC | 27,799 | $2.6M | 0.3% |
| 69 | PCVXVAXCYTE INC | 45,071 | $2.6M | 0.3% |
| 70 | CYTKCYTOKINETICS INCPUT | 30,000 | $2.6M | 0.3% |
| 71 | RLMDRELMADA THERAPEUTICS INC | 361,367 | $2.5M | 0.3% |
| 72 | VERAVERA THERAPEUTICS INC | 57,608 | $2.5M | 0.3% |
| 73 | VERAVERA THERAPEUTICS INCPUT | 50,000 | $2.1M | 0.3% |
| 74 | CELCCELCUITY INCCALL | 20,000 | $2.1M | 0.3% |
| 75 | ANNXANNEXON INCCALL | 353,200 | $2.0M | 0.3% |
| 76 | SEPNSEPTERNA INCPUT | 59,700 | $2.0M | 0.3% |
| 77 | CRVSCORVUS PHARMACEUTICALS INCCALL | 133,400 | $2.0M | 0.3% |
| 78 | CTNMCONTINEUM THERAPEUTICS INC | 119,733 | $2.0M | 0.2% |
| 79 | BCYCBICYCLE THERAPEUTICS PLC | 462,724 | $2.0M | 0.2% |
| 80 | GLUEMONTE ROSA THERAPEUTICS INC | 78,391 | $1.9M | 0.2% |
| 81 | CLDXCELLDEX THERAPEUTICS INC NEWCALL | 50,900 | $1.9M | 0.2% |
| 82 | VRDNVIRIDIAN THERAPEUTICS INC | 100,000 | $1.8M | 0.2% |
| 83 | MGNXMACROGENICS INC | 374,403 | $1.7M | 0.2% |
| 84 | PROQR THRAPEUTICS N V | 926,016 | $1.7M | 0.2% |
| 85 | ADMAADMA BIOLOGICS INCCALL | 200,000 | $1.7M | 0.2% |
| 86 | SPRBSPRUCE BIOSCIENCES INC | 30,000 | $1.6M | 0.2% |
| 87 | ARDXARDELYX INC | 303,025 | $1.5M | 0.2% |
| 88 | CUECUE BIOPHARMA INC | 48,369 | $1.5M | 0.2% |
| 89 | MLYSMINERALYS THERAPEUTICS INC | 56,347 | $1.5M | 0.2% |
| 90 | EYPTEYEPOINT INCCALL | 106,300 | $1.5M | 0.2% |
| 91 | SLSSELLAS LIFE SCIENCES GROUP IPUT | 100,000 | $1.5M | 0.2% |
| 92 | PROTHENA CORP PLC | 149,482 | $1.5M | 0.2% |
| 93 | VYGRVOYAGER THERAPEUTICS INC | 413,642 | $1.4M | 0.2% |
| 94 | UNCYUNICYCIVE THERAPEUTICS INC | 303,676 | $1.4M | 0.2% |
| 95 | PHATPHATHOM PHARMACEUTICALS INC | 129,950 | $1.4M | 0.2% |
| 96 | EOLSEVOLUS INCCALL | 200,000 | $1.4M | 0.2% |
| 97 | SYRESPYRE THERAPEUTICS INC | 15,000 | $1.3M | 0.2% |
| 98 | HELPCYBIN INC | 200,000 | $1.3M | 0.2% |
| 99 | CRMDCORMEDIX INCPUT | 167,500 | $1.3M | 0.2% |
| 100 | EDITEDITAS MEDICINE INCCALL | 400,000 | $1.3M | 0.2% |
Source: SEC Form 13F-HR, reporting period 2026-06-30. Values are the manager's filed June-30-style quarter-end marks, not live prices. Research, not investment advice.